Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07018726

Addressing Emotional Distress in Dyads of Persons With a Young Onset Dementia (YOD) and Their Care-partners

The purpose of the present investigation is to test the efficacy of a virtual, brief (6 sessions) dyadic (patient and care-partner together) intervention to prevent chronic emotional distress in dyads where one person is diagnosed with Young Onset Dementia (YOD). Through this study, we seek to address the unmet need of preventing chronic emotional distress in YOD dyads through a feasible, acceptable and credible program, and ideally enhance resiliency and improve wellbeing and quality of life in both members of the dyad.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Massachusetts General Hospital (MGH)

Boston, Massachusetts, 02114, United States

Location status: Recruiting

Location contact

Ana-Maria Vranceanu, PhD

CONTACT

[email protected]

617-724-4977

Ana-Maria Vranceanu, PhD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Between the ages of 18-65 at the time of enrollment [both patient and care-partner]
  • Diagnosis of young-onset dementia (FTD, PPA, AD, PCA, etc.) with symptom onset prior to age 65 [patient]
  • A designated care-partner willing and interested to participate [both patient and care-partner]
  • Received YOD diagnosis in the past 6 month [patient]
  • English fluency and literacy [both patient and care-partner]
  • Cognitive ability to understand study and research protocol in order to consent to study participation per referring neurologist [both patient and care-partner]
  • Patient and/or caregiver exhibit emotional distress on screening (using HADS D and/or HADS A scores > 7)

Exclusion criteria

  • An additional, terminal diagnosis such as cancer
  • Lack of access to internet and/or a device with a camera
  • Current untreated or unstable severe mental health conditions like bipolar disorder, schizophrenia, or active substance use

Treatment and study plan

Resilient Together-YOD

Behavioral

This is a 6 session dyadic (patient and spousal care-partner) intervention that teaches resiliency and interpersonal communication skills early after YOD diagnoses. It aims to decrease heightened symptoms of depression and anxiety among dyads to help them engage in important decisions around long term care-planning and optimize adjustment. The goal is to equip dyads with the necessary skills to cope and engage in meaningful, challenging conversations around care-planning, symptom deterioration, work/family planning to improve well-being in both members of the dyad.

Other names: Skills-based intervention

Health Enhancement Program-YOD

Behavioral

This is a 6 session program that will deliver educational information to dyads and will mimic the dose and duration of Resilient Together. The program will not teach any individual and dyadic interpersonal skills, but will contain education on psychological distress and healthy behaviors. Sessions will also be delivered virtually.

Other names: Educational program

Primary outcomes

  1. Change in Emotional Distress

    Time frame: 0 weeks, 6 weeks, 12 weeks

    Hospital Depression and Anxiety Scale total score (HADS); 0-21 for each subscale (anxiety and depression), higher scores indicate greater anxiety or depression

Secondary outcomes

  1. Change in Resiliency Factors (Mindfulness)

    Time frame: 0 weeks, 6 weeks, 12 weeks

    Cognitive and Affective Mindfulness Scale (CAMS); 12-48, higher scores indicate greater perceived mindfulness

  2. Change in Resiliency Factors (Individual Coping)

    Time frame: 0 week, 6 weeks, 12 weeks

    Measure of Current Status Part A (MOCS-A) Assertiveness and Coping Confidence subscales; Subscale scores: 0-4; higher scores indicate greater perceived ability to cope

  3. Change in Resiliency Factors (Mindfulness Utilization)

    Time frame: 0 weeks, 6 weeks, 12 weeks

    Applied Mindfulness Scale (AMPS); 0-60, higher scores indicate greater use of mindfulness practices.

  4. Changes in Interpersonal Factors (Dyad Coping)

    Time frame: 0 weeks, 6 weeks, 12 weeks

    Dyadic Coping Inventory (DCI); 37-185, higher scores indicate greater perceived coping in the context of a relationship

  5. Changes in Resiliency Factors (Perceived Social Support)

    Time frame: 0 weeks, 6 weeks, 12 weeks

    Multidimensional Scale of Perceived Social Support (MSPSS); 12-84, higher scores indicate greater perceived social support from family, friends, and significant others

  6. Changes in Resiliency Factors (Values-based Living)

    Time frame: 0 weeks, 6 weeks, 12 weeks

    Valuing Questionnaire (VQ); Progress and Obstruction Subscale Scores: 0-30, higher scores indicate living in greater accordance with one's values

Other outcomes

  1. Global Impressions of Change

    Time frame: 6 weeks, 12 weeks

    Modified Global Impressions of Chance (MGIC); 1-7, higher scores indicate greater perceived change in outcomes

  2. Cognition

    Time frame: 0 weeks

    Montreal Cognitive Assessment (MoCA); 0-30, lower scores indicate greater cognitive dysfunction

Study contacts

Contact information is provided by the study sponsor or research team.

Ana-Maria Vranceanu, PhD

CONTACT

[email protected]

617-724-4977

Maggie L Syme, PhD, MPH

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Massachusetts General Hospital

Other

Registry information

Important dates

Study start
2026
Primary completion
2030
Study completion
2031
First posted
Jun 12, 2025
Registry last updated
Apr 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.